73 Cited authorities

  1. Ashcroft v. Iqbal

    556 U.S. 662 (2009)   Cited 252,459 times   279 Legal Analyses
    Holding that a claim is plausible where a plaintiff's allegations enable the court to draw a "reasonable inference" the defendant is liable
  2. Bell Atl. Corp. v. Twombly

    550 U.S. 544 (2007)   Cited 266,381 times   365 Legal Analyses
    Holding that a complaint's allegations should "contain sufficient factual matter, accepted as true, to 'state a claim to relief that is plausible on its face' "
  3. Lujan v. Defs. of Wildlife

    504 U.S. 555 (1992)   Cited 27,812 times   138 Legal Analyses
    Holding that the elements of standing "must be supported in the same way as any other matter on which the plaintiff bears the burden of proof"
  4. Steel Co. v. Citizens for Better Env't

    523 U.S. 83 (1998)   Cited 10,721 times   15 Legal Analyses
    Holding that a court "act ultra vires" when it assumes "hypothetical jurisdiction" in order to rule on the merits
  5. Warth v. Seldin

    422 U.S. 490 (1975)   Cited 11,858 times   14 Legal Analyses
    Holding that Article III requires plaintiffs "to establish that, in fact, the asserted injury was the consequence of the defendants' actions"
  6. Los Angeles v. Lyons

    461 U.S. 95 (1983)   Cited 7,500 times   13 Legal Analyses
    Holding there is no justiciable controversy where plaintiff had once been subjected to a chokehold
  7. O'Shea v. Littleton

    414 U.S. 488 (1974)   Cited 4,082 times   5 Legal Analyses
    Holding that "[p]ast exposure to illegal conduct does not in itself show a present case or controversy regarding injunctive relief ... if unaccompanied by any continuing, present adverse effects"
  8. Mandarin v. Wildenstein

    2011 N.Y. Slip Op. 741 (N.Y. 2011)   Cited 1,603 times   5 Legal Analyses
    Holding that plaintiff must allege a misrepresentation or a material omission of fact which was "false and known to be false"
  9. Jones v. Rath Packing Co.

    430 U.S. 519 (1977)   Cited 1,187 times   3 Legal Analyses
    Holding that the presumption is weaker, if triggered at all, where there is not a tradition of state legislation
  10. Lorillard Tobacco Co. v. Reilly

    533 U.S. 525 (2001)   Cited 506 times   3 Legal Analyses
    Holding that a ban on outdoor advertising of smokeless tobacco and cigars within one thousand feet of a school or playground violated the First Amendment
  11. Rule 12 - Defenses and Objections: When and How Presented; Motion for Judgment on the Pleadings; Consolidating Motions; Waiving Defenses; Pretrial Hearing

    Fed. R. Civ. P. 12   Cited 345,620 times   922 Legal Analyses
    Granting the court discretion to exclude matters outside the pleadings presented to the court in defense of a motion to dismiss
  12. Section 349 - Deceptive acts and practices unlawful

    N.Y. Gen. Bus. Law § 349   Cited 4,807 times   106 Legal Analyses
    Granting "any person who has been injured by reason of any violation of this section" the right to "bring an action in his own name"
  13. Section 321 - Definitions; generally

    21 U.S.C. § 321   Cited 1,166 times   161 Legal Analyses
    Defining “new drug”
  14. Section 352 - Misbranded drugs and devices

    21 U.S.C. § 352   Cited 739 times   73 Legal Analyses
    Setting labeling requirements for drug products
  15. Section 343 - Misbranded food

    21 U.S.C. § 343   Cited 568 times   59 Legal Analyses
    Setting labeling requirements for food products
  16. Section 601 - Definitions

    21 U.S.C. § 601   Cited 178 times   10 Legal Analyses
    Defining "misbranded" meat product in part as one with "labeling is false or misleading in any particular"
  17. Section 451 - Congressional statement of findings

    21 U.S.C. § 451   Cited 102 times   2 Legal Analyses
    In 21 U.S.C. § 451, Congress bases the entire PPIA on its finding that "[u]nwholesome, adulterated, or misbranded poultry products" hurt people and destroy markets for poultry.
  18. Section 379r - National uniformity for nonprescription drugs

    21 U.S.C. § 379r   Cited 98 times   16 Legal Analyses
    Labeling requirements for nonprescription drugs
  19. Section 362 - Misbranded cosmetics

    21 U.S.C. § 362   Cited 34 times   11 Legal Analyses
    Prohibiting such labeling in cosmetics
  20. Section 379s - Preemption for labeling or packaging of cosmetics

    21 U.S.C. § 379s   Cited 30 times   4 Legal Analyses
    Labeling and packaging requirements for cosmetics
  21. Section 100.100 - Misleading containers

    21 C.F.R. § 100.100   Cited 43 times   13 Legal Analyses
    Defining misbranded food containers
  22. Section 301.2 - Definitions

    9 C.F.R. § 301.2   Cited 22 times   3 Legal Analyses
    Defining "dying, diseased, or disabled livestock" as including animals displaying a "lack of muscle coordination" or an "inability to walk normally or stand"
  23. Section 317.8 - [Effective 5/17/2024] False or misleading labeling or practices generally; specific prohibitions and requirements for labels and containers

    9 C.F.R. § 317.8   Cited 15 times   2 Legal Analyses

    (a) No product or any of its wrappers, packaging, or other containers shall bear any false or misleading marking, label, or other labeling and no statement, word, picture, design, or device which conveys any false impression or gives any false indication of origin or quality or is otherwise false or misleading shall appear in any marking or other labeling. No product shall be wholly or partly enclosed in any wrapper, packaging, or other container that is so made, formed, or filled as to be misleading

  24. Section 381.1 - Definitions

    9 C.F.R. § 381.1   Cited 5 times   3 Legal Analyses

    (a) For the purposes of the regulations in this part, unless otherwise required by the context, the singular form shall also import the plural and the masculine form shall also import the feminine, and vice versa. (b) For the purposes of such regulations, unless otherwise required by the context, the following terms shall be construed, respectively, to mean: Acceptable. "Acceptable" means suitable for the purpose intended and acceptable to the Administrator. Act. "Act" means the Poultry Products

  25. Section 701.1 - Misbranding

    21 C.F.R. § 701.1   Cited 5 times
    Labeling “may be misleading” where it designates the cosmetic “by a name which includes or suggests the name of one or more but not all ... ingredients”
  26. Section 201.60 - Principal display panel

    21 C.F.R. § 201.60   Cited 3 times

    The term principal display panel, as it applies to over-the-counter drugs in package form and as used in this part, means the part of a label that is most likely to be displayed, presented, shown, or examined under customary conditions of display for retail sale. The principal display panel shall be large enough to accommodate all the mandatory label information required to be placed thereon by this part with clarity and conspicuousness and without obscuring designs, vignettes, or crowding. Where

  27. Section 201.62 - Declaration of net quantity of contents

    21 C.F.R. § 201.62   Cited 3 times

    (a) The label of an over-the-counter drug in package form shall bear a declaration of the net quantity of contents. This shall be expressed in the terms of weight, measure, numerical count, or a combination or numerical count and weight, measure, or size. The statement of quantity of drugs in tablet, capsule, ampule, or other unit form and the quantity of devices shall be expressed in terms of numerical count; the statement of quantity for drugs in other dosage forms shall be in terms of weight if

  28. Section 701.10 - Principal display panel

    21 C.F.R. § 701.10   Cited 1 times

    The term principal display panel as it applies to cosmetics in package form and as used in this part, means the part of a label that is most likely to be displayed, presented, shown, or examined under customary conditions of display for retail sale. The principal display panel shall be large enough to accommodate all the mandatory label information required to be placed thereon by this part with clarity and conspicuousness and without obscuring designs, vignettes, or crowding. Where packages bear

  29. Section 350.1 - Scope

    21 C.F.R. § 350.1

    (a) An over-the-counter antiperspirant drug product in a form suitable for topical administration is generally recognized as safe and effective and is not misbranded if it meets each condition in this part and each general condition established in § 330.1 of this chapter. (b) References in this part to regulatory sections of the Code of Federal Regulations are to chapter I of title 21 unless otherwise noted. 21 C.F.R. §350.1